Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions

Decreased major histocompatibility class II (MHCII) expression is associated with poor survival in diffuse large B-cell lymphoma (DLBCL). Immune-privileged site DLBCL (IP-DLBCL) patients reportedly have frequent large deletions at the MHCII locus whereas the mechanism of decreased expression in non-...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Rimsza, Lisa M., Roberts, Robin A., Campo, Elias, Grogan, Thomas M., Bea, Silvia, Salaverria, Itziar, Zettl, Andreas, Rosenwald, Andreas, Ott, German, Muller-Hermelink, H. Konrad, Delabie, Jan, Fisher, Richard I., Unger, Joseph M., LeBlanc, Michael, Staudt, Louis M., Jaffe, Elaine S., Gascoyne, Randy D., Chan, Wing C., Weisenburger, Dennis D., Greiner, Timothy, Braziel, Rita M., Miller, Thomas P.
פורמט: Artigo
שפה:Inglês
יצא לאור: © 2006 by The American Society of Hematology 2006
נושאים:
Neoplasia
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC1895908/
https://ncbi.nlm.nih.gov/pubmed/16239429
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2005-04-1510
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים